Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3616934
Max Phase: Preclinical
Molecular Formula: C56H81N13O10
Molecular Weight: 1096.34
Molecule Type: Protein
Associated Items:
ID: ALA3616934
Max Phase: Preclinical
Molecular Formula: C56H81N13O10
Molecular Weight: 1096.34
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC(C)C[C@@H]1NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCN)NC(=O)[C@@H](NC(=O)[C@@H](CCN)NC(=O)OCC2c3ccccc3-c3ccccc32)CCNC1=O
Standard InChI: InChI=1S/C56H81N13O10/c1-32(2)28-45-48(70)61-27-22-44(65-52(74)43(21-26-60)69-56(78)79-31-39-37-16-10-8-14-35(37)36-15-9-11-17-38(36)39)53(75)63-42(20-25-59)51(73)67-46(29-33(3)4)54(76)68-47(30-34-12-6-5-7-13-34)55(77)64-40(18-23-57)49(71)62-41(19-24-58)50(72)66-45/h5-17,32-33,39-47H,18-31,57-60H2,1-4H3,(H,61,70)(H,62,71)(H,63,75)(H,64,77)(H,65,74)(H,66,72)(H,67,73)(H,68,76)(H,69,78)/t40-,41-,42-,43+,44-,45-,46-,47+/m0/s1
Standard InChI Key: BQYVQYLAKWLSLF-JPFWLQGRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1096.34 | Molecular Weight (Monoisotopic): 1095.6229 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. De Zoysa GH, Cameron AJ, Hegde VV, Raghothama S, Sarojini V.. (2015) Antimicrobial peptides with potential for biofilm eradication: synthesis and structure activity relationship studies of battacin peptides., 58 (2): [PMID:25495219] [10.1021/jm501084q] |
Source(1):